Search

Search Constraints

You searched for: Author/Creator Hirai, Fumihiko

Search Results

2. Association of preoperative serum CRP with PD-L1 expression in 508 patients with non-small cell lung cancer: A comprehensive analysis of systemic inflammatory markers. (March 2018)

3. Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting. Issue 2 (26th March 2021)

4. Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients. Issue 1 (9th November 2017)

5. Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors. (December 2018)

6. Feasibility of the administration of chemotherapy using cisplatin plus etoposide for non-small cell lung cancer patients with interstitial lung disease on chest computed tomography. (2017)

7. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. (September 2015)

8. Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non–small-cell Lung Cancer Exhibiting Resistance to Ceritinib. Issue 7 (July 2015)

9. Identification of a Novel ALK G1123S Mutation in a Patient with ALK-rearranged Non–small-cell Lung Cancer Exhibiting Resistance to Ceritinib. Issue 7 (July 2015)

10. Indoleamine 2, 3-dioxygenase 1 and programmed cell death-ligand 1 co-expression correlates with aggressive features in lung adenocarcinoma. (September 2018)